Dr Teresa Wozniak
Research fellow
Qualifications:
PhD, University of NSW, 2016; PhD, University of Sydney, 2007; Master of Public Health, University of Sydney, 2010; Bachelor of Medical Science (Hon), Macquarie University and University of Tasmania, 2001
Approved level of HDR supervision at Charles Darwin University:
Co-supervisor for a PhD Student
Location:
Biography:
Teresa is passionate about research that generates positive impact on the population and health policy. She started her career in medical research and later retrained as an epidemiologist. Teresa leads a group on antimicrobial resistance at the Menzies School of Health Research where her focus is on developing tools to monitor, share and use disease surveillance data. Such data are essential to determine the biological and social drivers of antimicrobial resistance. Teresa works collaboratively with infectious disease modellers, informaticians, policy-makers and social scientists to determine drivers of antimicrobial resistance, in particular focusing on low-resource settings (regional Australia and Timor-Leste).
Teresa is enthusiastic about diversity of thought , partnering together to achieve common goals and building interdisciplinary professional networks. In 2017, she founded the Women in Tropical Health (WITH) network and in 2018, together with Menzies' development team, launched the first of its kind mentoring program. The Catalyse mentorship program matches women working in regional areas with mentors from sectors including business and health industry to provide a holistic approach to improving career satisfaction, institutional productivity and supporting a diverse workforce.
Research Themes
-
Championing women working in health across regional and rural Australia – a new dual-mentorship model
Mentoring is a critical component of career development and job satisfaction leading to a healthier workforce and more productive outputs.
-
Combacte-Magnet EPI-Net | AMR Blind spots
Dr Teresa Wozniak and her team are committed to strengthening disease surveillance and response to AMR containment.
-
Territory FM | Mel Little chats with Dr Teresa Wozniak – Research Fellow, Menzies School of Health Research.
At Menzies Dr Wozniak is establishing a real-time surveillance system focusing on key drug-resistant infections across northern Australia. Regionally-relevant data are needed to inform infection prevention and control efforts and support the development of local and national treatment guidelines.
-
Menzies Superstars of Stem
On a quiet Friday afternoon at Menzies, an emergency breaks out that only our #superstarsofSTEM can solve. An International Women's Day project.
-
Youth leaders learn about health hurdles of NT
Th Sun Newspapers | The Ship for World Youth Leaders (SWY) program, have visited the Menzies School of Health Research (Menzies)
-
International youth leaders sail into Menzies School of Health Research
The Ship for World Youth Leaders (SWY) program, have visited the Menzies School of Health Research (Menzies) to learn about some of the key public health challenges in the region.
-
Menzies School of Health Research home to three superstars of STEM
Three Menzies School of Health Research researchers are among the new round of 2019 Superstars of STEM.
-
Our North, Our Future
Northern Australia is becoming an economic powerhouse, delivering economic, social and environmental benefits to all Australians. The Our North, Our Future video on northern Australia showcases the progress occurring across the north, told by the people who live, work and do business in this thriving region.
-
Antibiotic Resistance: The Epidemic Is Here
Welcome to the world of antibiotic resistance, where superbugs will put the lives of everyone from chemotherapy patients to those with a sexually transmitted infection or even a simple graze at risk.
-
HOT NORTH Visiting Fellow, Arca Testamenti Travels to Darwin
HSP recently partnered with the Menzies School of Health Research in Darwin, Australia to support a HOT NORTH Visiting Fellowship for an exceptional graduate student from Indonesia’s Bogor Agricultural University.
-
Katherine doctors push for more public housing
Katherine Times reports on the HOT NORTH Teaching Workshop.
- Wozniak, T.M., Miller, E., Williams, K. & Pickering, A. (2020). Championing women working in health across regional and rural Australia - a new dual-mentorship model. BMC Medical Education, 20: 299. doi: 10.1186/s12909-020-02219-w
- Wozniak, T.M., Cuningham, W., Buchanan, S., Coulter, S., Baird, R.W., Nimmo, G.R., Blyth, C.C., Tong, S.Y.C., Currie, B.J. & Ralph, A.P. (2020). Geospatial epidemiology of Staphylococcus aureus in a tropical setting: an enabling digital surveillance platform. Scientific Reports, 10: 13169. doi: 10.1038/s41598-020-69312-4
- Lee, X.J., Stewardson, A.J., Worth, L.J., Graves, N. & Wozniak, T.M. (2020). Attributable length of stay, mortality risk and costs of bacterial healthcare-associated infections in Australia: a retrospective case-cohort study. Clinical Infectious Diseases, ciaa1228. doi: 10.1093/cid/ciaa1228
- Wozniak, T.M., Bailey, E. & Graves, N. (2019). Health and economic burden of antimicrobial-resistant infections in Australian hospitals: a population-based model. Infection Control & Hospital Epi, 40(3), 320-7. doi: 10.1017/ice.2019.2.
- Wozniak, T.M., Barnsbee, L., Lee, X. & Pacella, R. (2019). Using the best available data to estimate the cost of antimicrobial resistance: a systematic review. Antimicrobial Resistance and Infection Control, 8: 26. doi: 10.1186/s13756-019-0472-z.
- Wozniak, T.M. (2018). Letter to the editor in response to estimating the burden of antimicrobial resistance: a systematic literature review. Antimicrobial Resistance and Infection Control, 7: 91. doi: 10.1186/s13756-018-0379-0.
- Wozniak, T.M. (2018). Clinical management of drug-resistant bacteria in Australian hospitals: an online survey of doctors' opinions. Infection, Disease & Health, 23(1): 41-48. doi: 10.1016/j.idh.2017.11.003.
- Wozniak, T.M., Graves, N. & Barnett, A. (2018). How much do superbugs cost? An evidence-based open-access tool. Infection, Disease & Health, 23(1): 54-56. doi: 10.1016/j.idh.2017.